Vistagen Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.27

+0.00 (+0.49%)

As of Aug 14, 10:18 PM ET ·

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 7 70%

Sell 3 30%

Price Target

Analyst Price Target +18,386.5% upside

Low Target $36.23

Average Target $49.47

High Target $53.77

Current Price $0.27

Current
$0.27

Target
$49.47

$36.23 $49.47 avg $53.77

Scenario Analysis

Bear Case

$36.23

13,438.9%

Low target

Base Case

$49.47

+18,386.5%

Avg target

Bull Case

$53.77

+19,993.4%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$5.14

-94.8% from high

52-Week Low

$0.20

+35.2% from low

Target vs 52W High

$49.47

+862.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	+3.3%
AMGN Amgen Inc	Hold	43	49%	$190.87	-54.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	37	81%	$438.34	-13.3%
REGN Regeneron Pharmaceuticals	Buy	37	70%	$76.80	-90.4%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-53.9%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.0%
BIIB Biogen Inc	Buy	43	67%	$91.45	-56.4%